BACKGROUND: Neurofibrillary tangles seen early in Alzheimer disease (AD) initially appear in a subregion of the perirhinal cortex. In the monkey, damage to the perirhinal cortex impairs performance on visual recognition memory tasks. The authors evaluated impairment of visual recognition memory as a potential early diagnostic marker of AD. METHODS: The authors developed a visual delayed matching-to-sample task (DMS48) designed to assess visual recognition memory in humans. Twenty-three patients fulfilling the criteria of amnestic mild cognitive impairment (MCI) (mean Mini-Mental State Examination [MMSE]: 26.6, SD = 1.6) were recruited. All underwent a full neuropsychological evaluation, which included the Free and Cued Selective Reminding (FCSR) test. Their performance was compared with that of 10 patients with mild AD, 20 patients with moderate AD, 20 patients with Parkinson disease (PD), and 40 age-matched controls. RESULTS: Control subjects and patients with PD performed close to ceiling. Patients with mild AD had very low scores, while patients with moderate AD answered at random. MCI patients obtained scores that were between those of control subjects and patients with mild AD (78%, SD = 16%). MCI patients who failed on the DMS48 had lower scores on free recall (p < 0.05) and received less benefit from cueing (p < 0.01) on the FCSR than the other MCI, suggesting a profile of genuine memory impairment related to medial temporal lobe lesions. CONCLUSION: The DMS48, a test of visual recognition memory, is impaired early in the course of patients with MCI. Further studies are necessary to determine whether the evaluation of visual recognition memory may contribute to the identification of patients with AD.
BACKGROUND: Neurofibrillary tangles seen early in Alzheimer disease (AD) initially appear in a subregion of the perirhinal cortex. In the monkey, damage to the perirhinal cortex impairs performance on visual recognition memory tasks. The authors evaluated impairment of visual recognition memory as a potential early diagnostic marker of AD. METHODS: The authors developed a visual delayed matching-to-sample task (DMS48) designed to assess visual recognition memory in humans. Twenty-three patients fulfilling the criteria of amnestic mild cognitive impairment (MCI) (mean Mini-Mental State Examination [MMSE]: 26.6, SD = 1.6) were recruited. All underwent a full neuropsychological evaluation, which included the Free and Cued Selective Reminding (FCSR) test. Their performance was compared with that of 10 patients with mild AD, 20 patients with moderate AD, 20 patients with Parkinson disease (PD), and 40 age-matched controls. RESULTS: Control subjects and patients with PD performed close to ceiling. Patients with mild AD had very low scores, while patients with moderate AD answered at random. MCI patients obtained scores that were between those of control subjects and patients with mild AD (78%, SD = 16%). MCI patients who failed on the DMS48 had lower scores on free recall (p < 0.05) and received less benefit from cueing (p < 0.01) on the FCSR than the other MCI, suggesting a profile of genuine memory impairment related to medial temporal lobe lesions. CONCLUSION: The DMS48, a test of visual recognition memory, is impaired early in the course of patients with MCI. Further studies are necessary to determine whether the evaluation of visual recognition memory may contribute to the identification of patients with AD.
Authors: Paul L Soto; Nancy A Ator; Sundari K Rallapalli; Poonam Biawat; Terry Clayton; James M Cook; Michael R Weed Journal: Neuropsychopharmacology Date: 2013-05-31 Impact factor: 7.853
Authors: J Delrieu; T Voisin; S Andrieu; S Belliard; J Belmin; F Blanchard; M Ceccaldi; J F Dartigues; B Defontaines; S Lehericy; C Mekies; O Moreaud; L Naccache; F Nourhashemi; P J Ousset; F Pasquier; P Payoux; F Puisieux; P Robert; J Touchon; B Vellas; B Dubois Journal: J Nutr Health Aging Date: 2009-06 Impact factor: 4.075
Authors: Elsa Kaphan; Emmanuel Barbeau; Marie L Royère; Eric Guedj; Jean Pelletier; André Ali Chérif Journal: Arch Clin Neuropsychol Date: 2014-10-03 Impact factor: 2.813
Authors: Maude Joannette; Christian Bocti; Pénélope Sévigny Dupont; Marie Maxime Lavallée; Jim Nikelski; Guillaume T Vallet; Howard Chertkow; Sven Joubert Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-25 Impact factor: 6.053
Authors: K Mondon; A Gochard; A Marqué; A Armand; D Beauchamp; C Prunier; D Jacobi; B de Toffol; A Autret; V Camus; C Hommet Journal: J Neurol Neurosurg Psychiatry Date: 2007-02-07 Impact factor: 10.154